# Fluorescent Sentinel Lymph Node Identification in Colon Carcinoma Using Submucosal Bevacizumab-800CW.

> **NCT05498051** · NA · COMPLETED · sponsor: **Meander Medical Center** · enrollment: 5 (actual)

## Conditions studied

- Colonic Neoplasms
- Sentinel Lymph Node
- Fluorescence
- Colorectal Neoplasms

## Interventions

- **PROCEDURE:** Sentinel lymph node identification

## Key facts

- **NCT ID:** NCT05498051
- **Lead sponsor:** Meander Medical Center
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2022-09-01
- **Primary completion:** 2023-02-01
- **Final completion:** 2023-06-01
- **Target enrollment:** 5 (ACTUAL)
- **Last updated:** 2023-07-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05498051

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05498051, "Fluorescent Sentinel Lymph Node Identification in Colon Carcinoma Using Submucosal Bevacizumab-800CW.". Retrieved via AI Analytics 2026-07-26 from https://api.ai-analytics.org/clinical/NCT05498051. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*